Three things to know:
1. Biogennix designs, manufactures and distributes bone graft substitutes for bone fusion procedures.
2. The company is expanding its sales team, manufacturing capacity and research and development program.
3. Its bone grafting products — Morpheus and osteoSPAN — are resorbable, osteoconductive scaffolds that are used for bone regeneration.
More articles on devices:
Misonix ultrasonic device earns CE Mark approval — 4 insights
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
